Kumar Mishra Shrawan, Singh Prabhat, Rath Srikanta Kumar
Genotoxicity Laboratory, Toxicology Division, CSIR-Central Drug Research Institute (CDRI), Lucknow 226 001, India.
Malar Res Treat. 2013;2013:141734. doi: 10.1155/2013/141734. Epub 2013 Mar 27.
The present study was aimed to find out the protective effect of quercetin on hepatotoxicity resulting by commonly used antimalarial drug chloroquine (CQ). Swiss albino mice were administered with different amounts of CQ ranging from human therapeutic equivalent of 360 mg/kg body wt. to as high as 2000 mg/kg body wt. We observed statistically significant generation of reactive oxygen species, liver toxicity, and oxidative stress. Our observation of alterations in biochemical parameters was strongly supported by real-time PCR measurement of mRNA expression of key biochemical enzymes involved in hepatic toxicity and oxidative stress. However, the observed hepatotoxicity and accompanying oxidative stress following CQ administration show dose specific pattern with little or apparently no effect at therapeutic dose while having severe effects at higher dosages. We further tested quercetin, an antioxidant flavanoid, against CQ-induced hepatoxicity and found encouraging results as quercetin was able to drastically reduce the oxidative stress and hepatotoxicity resulting at higher dosages of CQ administration. In conclusion, our study strongly suggests co administration of antioxidant flavonoid like quercetin along with CQ for antimalarial therapy. This is particularly important when CQ is administered as long-term prophylactic treatment for malaria as chronic exposure has shown to be resulting in higher dose level of drug in the body.
本研究旨在探究槲皮素对常用抗疟药物氯喹(CQ)所致肝毒性的保护作用。给瑞士白化小鼠施用不同剂量的CQ,剂量范围从人体治疗等效剂量360毫克/千克体重到高达2000毫克/千克体重。我们观察到活性氧的产生、肝毒性和氧化应激具有统计学意义。通过实时PCR测量参与肝毒性和氧化应激的关键生化酶的mRNA表达,有力地支持了我们对生化参数变化的观察。然而,CQ给药后观察到的肝毒性和伴随的氧化应激呈现剂量特异性模式,在治疗剂量时几乎没有或明显没有影响,而在较高剂量时则有严重影响。我们进一步测试了抗氧化类黄酮槲皮素对CQ诱导的肝毒性的作用,发现了令人鼓舞的结果,因为槲皮素能够大幅降低高剂量CQ给药时产生的氧化应激和肝毒性。总之,我们的研究强烈建议在抗疟治疗中,将槲皮素等抗氧化类黄酮与CQ联合使用。当CQ作为疟疾的长期预防性治疗药物时,这一点尤为重要,因为长期接触已表明会导致体内药物剂量水平升高。